Allogeneic stem cell transplantation for children and adolescents/young adults with de novo blastic phase chronic myeloid leukemia in the tyrosine kinase inhibitor era

The analysis of 165 children and adolescents/young adults with de novo blastic phase chronic myeloid leukemia showed disease status at hematopoietic stem cell transplantation was a strong prognostic factor and clearly separated the patient outcomes.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of hematology 2023-08, Vol.98 (8), p.E200-E203
Hauptverfasser:	Ishida, Hisashi, Shimada, Hiroyuki, Tanizawa, Akihiko, Shimazu, Yutaka, Tachibana, Takayoshi, Doki, Noriko, Ara, Takahide, Matsuo, Yayoi, Nara, Miho, Toubai, Tomomi, Ino, Kazuko, Nakamae, Hirohisa, Kato, Keisuke, Kato, Koji, Sato, Atsushi, Hino, Moeko, Matsumoto, Kimikazu, Atsuta, Yoshiko, Yasui, Masahiro, Nagamura‐Inoue, Tokiko
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adolescents Allografts Child Chronic myeloid leukemia Hematology Hematopoietic Stem Cell Transplantation Hematopoietic stem cells Humans Leukemia, Myelogenous, Chronic, BCR-ABL Positive - therapy Myeloid leukemia Protein Kinase Inhibitors - pharmacology Protein Kinase Inhibitors - therapeutic use Retrospective Studies Stem cell transplantation Transplantation, Homologous Tyrosine Kinase Inhibitors Young Adult Young adults
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The analysis of 165 children and adolescents/young adults with de novo blastic phase chronic myeloid leukemia showed disease status at hematopoietic stem cell transplantation was a strong prognostic factor and clearly separated the patient outcomes.
ISSN:	0361-8609 1096-8652
DOI:	10.1002/ajh.26959